Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12398838rdf:typepubmed:Citationlld:pubmed
pubmed-article:12398838lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:12398838lifeskim:mentionsumls-concept:C0026848lld:lifeskim
pubmed-article:12398838lifeskim:mentionsumls-concept:C0441635lld:lifeskim
pubmed-article:12398838lifeskim:mentionsumls-concept:C0242697lld:lifeskim
pubmed-article:12398838lifeskim:mentionsumls-concept:C0012929lld:lifeskim
pubmed-article:12398838lifeskim:mentionsumls-concept:C0010749lld:lifeskim
pubmed-article:12398838lifeskim:mentionsumls-concept:C1444754lld:lifeskim
pubmed-article:12398838pubmed:issue9lld:pubmed
pubmed-article:12398838pubmed:dateCreated2002-10-25lld:pubmed
pubmed-article:12398838pubmed:abstractTextHeteroplasmic mitochondrial DNA mutations often cause a skeletal myopathy associated with a mosaic distribution of cytochrome c oxidase-deficient muscle fibres. The function of an individual muscle fibre is dependent upon the metabolic activity throughout its length, but little is known about the length of cytochrome c oxidase-deficient segments in human skeletal muscle in patients with mitochondrial disease. We studied cytochrome c oxidase activity by serial section analysis of quadriceps muscle from two patients. We observed a striking variation in the length of the cytochrome c oxidase-negative segments. The shortest segments were 10 microm long, and the longest segment was the entire length of the larger biopsy (> or =1.2 mm). The lengths of the cytochrome c oxidase-negative segments were generally shorter in the less severely affected biopsy, and we frequently observed non-contiguous segments of cytochrome c oxidase deficiency within the same muscle fibre. The findings have important implications for our understanding of the pathogenesis and progression of mitochondrial DNA myopathy.lld:pubmed
pubmed-article:12398838pubmed:languageenglld:pubmed
pubmed-article:12398838pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12398838pubmed:citationSubsetIMlld:pubmed
pubmed-article:12398838pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12398838pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12398838pubmed:statusMEDLINElld:pubmed
pubmed-article:12398838pubmed:monthNovlld:pubmed
pubmed-article:12398838pubmed:issn0960-8966lld:pubmed
pubmed-article:12398838pubmed:authorpubmed-author:JohnsonMargar...lld:pubmed
pubmed-article:12398838pubmed:authorpubmed-author:TurnbullDougl...lld:pubmed
pubmed-article:12398838pubmed:authorpubmed-author:ChinneryPatri...lld:pubmed
pubmed-article:12398838pubmed:authorpubmed-author:ElsonJoanna...lld:pubmed
pubmed-article:12398838pubmed:authorpubmed-author:SamuelsDavid...lld:pubmed
pubmed-article:12398838pubmed:issnTypePrintlld:pubmed
pubmed-article:12398838pubmed:volume12lld:pubmed
pubmed-article:12398838pubmed:ownerNLMlld:pubmed
pubmed-article:12398838pubmed:authorsCompleteYlld:pubmed
pubmed-article:12398838pubmed:pagination858-64lld:pubmed
pubmed-article:12398838pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:12398838pubmed:meshHeadingpubmed-meshheading:12398838...lld:pubmed
pubmed-article:12398838pubmed:meshHeadingpubmed-meshheading:12398838...lld:pubmed
pubmed-article:12398838pubmed:meshHeadingpubmed-meshheading:12398838...lld:pubmed
pubmed-article:12398838pubmed:meshHeadingpubmed-meshheading:12398838...lld:pubmed
pubmed-article:12398838pubmed:meshHeadingpubmed-meshheading:12398838...lld:pubmed
pubmed-article:12398838pubmed:meshHeadingpubmed-meshheading:12398838...lld:pubmed
pubmed-article:12398838pubmed:meshHeadingpubmed-meshheading:12398838...lld:pubmed
pubmed-article:12398838pubmed:meshHeadingpubmed-meshheading:12398838...lld:pubmed
pubmed-article:12398838pubmed:meshHeadingpubmed-meshheading:12398838...lld:pubmed
pubmed-article:12398838pubmed:meshHeadingpubmed-meshheading:12398838...lld:pubmed
pubmed-article:12398838pubmed:meshHeadingpubmed-meshheading:12398838...lld:pubmed
pubmed-article:12398838pubmed:meshHeadingpubmed-meshheading:12398838...lld:pubmed
pubmed-article:12398838pubmed:meshHeadingpubmed-meshheading:12398838...lld:pubmed
pubmed-article:12398838pubmed:meshHeadingpubmed-meshheading:12398838...lld:pubmed
pubmed-article:12398838pubmed:meshHeadingpubmed-meshheading:12398838...lld:pubmed
pubmed-article:12398838pubmed:year2002lld:pubmed
pubmed-article:12398838pubmed:articleTitleThe length of cytochrome c oxidase-negative segments in muscle fibres in patients with mtDNA myopathy.lld:pubmed
pubmed-article:12398838pubmed:affiliationDepartment of Neurology, University of Newcastle upon Tyne, The Medical School, Framlington Place, NE2 4HH, Newcastle upon Tyne, UK.lld:pubmed
pubmed-article:12398838pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12398838pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:12398838pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:12398838pubmed:publicationTypeCase Reportslld:pubmed
pubmed-article:12398838pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12398838lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12398838lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12398838lld:pubmed